Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,207 papers from all fields of science
Search
Sign In
Create Free Account
statine
Known as:
4-amino-3-hydroxy-6-methylheptanoic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Amino Acids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
A simple microscale method for determining the relative stereochemistry of statine units.
A. Preciado
,
P. Williams
Journal of Organic Chemistry
2008
Corpus ID: 29617725
A simple method to determine the relative stereochemistry of statine amino acids (gamma-amino-beta-hydroxyacids) by using (1)H…
Expand
2007
2007
Macrocyclic Statine‐Based Inhibitors of BACE‐1
A. Barazza
,
M. Götz
,
+9 authors
L. Moroder
ChemBioChem
2007
Corpus ID: 38208252
Minimal sequence requirements for binding of substrate‐derived statine peptides to the aspartyl enzyme were established on the…
Expand
1990
1990
The selectivity of statine-based inhibitors against various human aspartic proteinases.
R. Jupp
,
B. Dunn
,
+7 authors
S. D. de Laszlo
Biochemical Journal
1990
Corpus ID: 34567059
The interactions of five human enzymes (renin, pepsin, gastricsin, cathepsin D and cathepsin E) and the aspartic proteinase from…
Expand
1988
1988
Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
J. Maibaum
,
D. Rich
Journal of Medicinal Chemistry
1988
Corpus ID: 25125550
Two new inhibitors, 4 and 5, of the aspartic proteinase porcine pepsin were synthesized. These compounds, which span the P4-P'3…
Expand
1987
1987
Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
S. Rosenberg
,
J. Plattner
,
+4 authors
T. Perun
Journal of Medicinal Chemistry
1987
Corpus ID: 27479234
Substituted 1,3- and 1,4-diamines were prepared from epoxides derived from Boc-leucine or Boc-cyclohexylalanine. These diamines…
Expand
1986
1986
Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin.
N. Agarwal
,
D. Rich
Journal of Medicinal Chemistry
1986
Corpus ID: 19055466
Five new cathepsin D inhibitors were synthesized and tested as inhibitors of bovine cathepsin D. The compounds were derived by…
Expand
Highly Cited
1985
Highly Cited
1985
Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
J. Boger
,
L. Payne
,
+7 authors
T. Lin
Journal of Medicinal Chemistry
1985
Corpus ID: 39572353
Analogues of the renin octapeptide substrate were synthesized in which replacement of the scissile dipeptide with (3S,4S)-4-amino…
Expand
Highly Cited
1985
Highly Cited
1985
Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.
D. Rich
,
M. Bernatowicz
,
N. Agarwal
,
M. Kawai
,
F. Salituro
,
P. Schmidt
Biochemistry
1985
Corpus ID: 12955874
The synthesis of 10 analogues of pepstatin modified so that statine is replaced by 4-amino-3-hydroxy-3,6-dimethylheptanoic acid…
Expand
Highly Cited
1984
Highly Cited
1984
Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs.
E. H. Blaine
,
T. W. Schorn
,
J. Boger
HYPERTENSION
1984
Corpus ID: 38000644
Iva-His-Pro-Phe-His-Sta-Leu-Phe-NH2 is a new, potent, specific statine -containing renin inhibitor. In vitro, the ID50 needed to…
Expand
1973
1973
Letter: X-ray structure determination of 4-amino-3-hydroxy-6-methylheptanoic acid, an amine component of pepstatin.
H. Nakamura
,
H. Morishima
,
T. Takita
,
H. Umezawa
,
Y. Iitaka
Journal of antibiotics (Tokyo. )
1973
Corpus ID: 29650796
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE